Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
Authors
Keywords
-
Journal
Science Immunology
Volume -, Issue -, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-11-01
DOI
10.1126/sciimmunol.add3899
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Humoral immune response after different SARS-CoV-2 vaccination regimens
- (2022) Ruben Rose et al. BMC Medicine
- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- Effectiveness of COVID-19 booster vaccines against covid-19 related symptoms, hospitalisation and death in England
- (2022) Nick Andrews et al. NATURE MEDICINE
- Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
- (2022) Rhia Kundu et al. Nature Communications
- Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients
- (2022) Corine H. GeurtsvanKessel et al. Science Immunology
- Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
- (2022) Jingyou Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
- (2021) Anthony T. Tan et al. Cell Reports
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
- (2021) Tatjana Bilich et al. Science Translational Medicine
- Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
- (2021) Tina Schmidt et al. NATURE MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
- (2021) Lucie Loyal et al. SCIENCE
- Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
- (2021) David Hillus et al. Lancet Respiratory Medicine
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
- (2021) Irene Cassaniti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
- (2021) Noam Barda et al. LANCET
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
- (2020) Annika Nelde et al. NATURE IMMUNOLOGY
- Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
- (2020) Lauren B. Rodda et al. CELL
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Reactivity of T Cells and Its Role in the Immune System
- (2013) Galina Petrova et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Precursor Frequency and Competition Dictate the HLA-A2-Restricted CD8+ T Cell Responses to Influenza A Infection and Vaccination in HLA-A2.1 Transgenic Mice
- (2011) A. C. L. Tan et al. JOURNAL OF IMMUNOLOGY
- The Multiple Mechanisms of T Cell Receptor Cross-reactivity
- (2009) Yiyuan Yin et al. IMMUNITY
- T Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular Flexibility
- (2009) Oleg Y. Borbulevych et al. IMMUNITY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started